US · Healthcare

Pathfinder Cell Therapy Inc (PFND)

Biotechnology

Pathfinder Cell Therapy Inc (PFND) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PFND

P/E ratio

18.00

Pathfinder Cell Therapy Inc (PFND) — FAQ

What is PFND's P/E ratio?

The price-to-earnings (P/E) ratio for Pathfinder Cell Therapy Inc (PFND) is 18.00 (data as of 2026-03-25).

Does Pathfinder Cell Therapy Inc pay a dividend?

Dividend yield is not available in the current snapshot for Pathfinder Cell Therapy Inc (PFND). Check the MyAverix Finance app for the latest dividend data.

What sector is Pathfinder Cell Therapy Inc in?

Pathfinder Cell Therapy Inc (PFND) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PFND listed on?

PFND is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)